Cohort Study on Biomarkers and Clinical Treatment of Tinnitus
Tinnitus, Subjective, Acoustic Stimulation, Transcranial Magnetic Stimulation, Repetitive
About this trial
This is an interventional treatment trial for Tinnitus, Subjective
Eligibility Criteria
Inclusion Criteria: Subjective tinnitus lasting for more than 6 months, with a score of>36 of the Tinnitus Disability Inventory (THI); The otoscopy examination showed that the ear canal and eardrum were normal, and the tympanic impedance maps of both ears were Type A, indicating that language ability met the requirements of language testing Exclusion Criteria: Family or congenital deafness history, ototoxicity drug use history, otitis media patients, etc Suffering from major physical diseases (sensory and motor disorders, neurological disorders, brain injuries, and other organic diseases) or mental disorders The patient has aggressive behavior and an impulse to damage the device Metal in the body (including orthodontics, dental implants), tattoos, and heart stent surgery Having claustrophobia Contraindications to magnetic resonance examination
Sites / Locations
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Acoustic stimulation therapy
Repetitive transcranial magnetic stimulation therapy
Patients in this group will receive acoustic stimulation therapy.
Patients in this group will receive repetitive transcranial magnetic stimulation therapy.